DV
Dividend Vision

ANIP — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. (ANIP)

Total return is -74.4% over the past 25.1 years, 1009.5 points behind SPY at 935.1%. Its deepest 1-year drawdown was 28.7%.

ANIP is a healthcare equity stock that focuses on pharmaceutical operations rather than functioning as a diversified ETF product. The fund does not currently report a distribution yield, expense ratio, or assets under management, suggesting it may not be actively traded as a traditional dividend-focused vehicle. This holding appeals primarily to investors seeking exposure to the pharmaceuticals sector rather than those targeting regular dividend income.

ANIP key facts

Asset type
Stock
Asset class
Equity
Inception date
07/24/2001
Distribution frequency
None
Last close
$76.54
Market cap
$1,758,150,784
Average volume
236800.0
Beta
0.464
Payout ratio
0.0
P/E ratio
16.6754
Forward P/E
8.5324
EPS
$4.59